BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9116268)

  • 1. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease.
    Mardiney M; Jackson SH; Spratt SK; Li F; Holland SM; Malech HL
    Blood; 1997 Apr; 89(7):2268-75. PubMed ID: 9116268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.
    Björgvinsdóttir H; Ding C; Pech N; Gifford MA; Li LL; Dinauer MC
    Blood; 1997 Jan; 89(1):41-8. PubMed ID: 8978275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease.
    Dinauer MC; Gifford MA; Pech N; Li LL; Emshwiller P
    Blood; 2001 Jun; 97(12):3738-45. PubMed ID: 11389011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-selected complete restoration of superoxide generation in Epstein-Barr virus-transformed B cells from p47phox-deficient chronic granulomatous disease patients by using a bicistronic retrovirus vector encoding a human multi-drug resistance gene (MDR1) and the p47phox gene.
    Iwata M; Nunoi H; Matsuda I; Kanegasaki S; Tsuruo T; Sugimoto Y
    Hum Genet; 1998 Oct; 103(4):419-23. PubMed ID: 9856484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic correction of p67phox deficient chronic granulomatous disease using peripheral blood progenitor cells as a target for retrovirus mediated gene transfer.
    Weil WM; Linton GF; Whiting-Theobald N; Vowells SJ; Rafferty SP; Li F; Malech HL
    Blood; 1997 Mar; 89(5):1754-61. PubMed ID: 9057660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
    Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
    Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells.
    Lavigne MC; Malech HL; Holland SM; Leto TL
    Circulation; 2001 Jul; 104(1):79-84. PubMed ID: 11435342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in gene therapy for chronic granulomatous disease.
    Malech HL
    J Infect Dis; 1999 Mar; 179 Suppl 2():S318-25. PubMed ID: 10081502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression.
    Sokolic RA; Sekhsaria S; Sugimoto Y; Whiting-Theobald N; Linton GF; Li F; Gottesman MM; Malech HL
    Blood; 1996 Jan; 87(1):42-50. PubMed ID: 8547675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p47phox mouse knock-out model of chronic granulomatous disease.
    Jackson SH; Gallin JI; Holland SM
    J Exp Med; 1995 Sep; 182(3):751-8. PubMed ID: 7650482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
    Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
    Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signed outside: a surface marker system for transgenic cytoplasmic proteins.
    Wohlgensinger V; Seger R; Ryan MD; Reichenbach J; Siler U
    Gene Ther; 2010 Oct; 17(10):1193-9. PubMed ID: 20445581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for chronic granulomatous disease.
    Kang EM; Malech HL
    Methods Enzymol; 2012; 507():125-54. PubMed ID: 22365772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral expression of recombinant p47phox protein by Epstein-Barr virus-transformed B lymphocytes from a patient with autosomal chronic granulomatous disease.
    Cobbs CS; Malech HL; Leto TL; Freeman SM; Blaese RM; Gallin JI; Lomax KJ
    Blood; 1992 Apr; 79(7):1829-35. PubMed ID: 1313715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease.
    Sekhsaria S; Gallin JI; Linton GF; Mallory RM; Mulligan RC; Malech HL
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7446-50. PubMed ID: 8395049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation.
    Sadat MA; Dirscherl S; Sastry L; Dantzer J; Pech N; Griffin S; Hawkins T; Zhao Y; Barese CN; Cross S; Orazi A; An C; Goebel WS; Yoder MC; Li X; Grez M; Cornetta K; Mooney SD; Dinauer MC
    Gene Ther; 2009 Dec; 16(12):1452-64. PubMed ID: 19657370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancer-deleted retroviral vectors restore high levels of superoxide generation in a mouse model of CGD.
    Schwickerath O; Brouns G; Thrasher A; Kinnon C; Roes J; Casimir C
    J Gene Med; 2004 Jun; 6(6):603-15. PubMed ID: 15170731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term high-level reconstitution of NADPH oxidase activity in murine X-linked chronic granulomatous disease using a bicistronic vector expressing gp91phox and a Delta LNGFR cell surface marker.
    Sadat MA; Pech N; Saulnier S; Leroy BA; Hossle JP; Grez M; Dinauer MC
    Hum Gene Ther; 2003 May; 14(7):651-66. PubMed ID: 12804147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for chronic granulomatous disease.
    Barese CN; Goebel WS; Dinauer MC
    Expert Opin Biol Ther; 2004 Sep; 4(9):1423-34. PubMed ID: 15335310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.
    Brenner S; Whiting-Theobald NL; Linton GF; Holmes KL; Anderson-Cohen M; Kelly PF; Vanin EF; Pilon AM; Bodine DM; Horwitz ME; Malech HL
    Blood; 2003 Oct; 102(8):2789-97. PubMed ID: 12829597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.